Preclinical and clinical evaluation of the siddha classical drug ATHIMADHURA KULIGAI(oral administration) along with KADUGU ENNAI (external application) in the management of AUTISM SPECTRUM DISORDER.
Phase 2
Completed
- Conditions
- Autistic disorder,
- Registration Number
- CTRI/2022/02/039889
- Lead Sponsor
- DrBTamil Elakkiya
- Brief Summary
It is a single arm clinical trial for preclinical and clinical evaluation of the effect on oral administration of ATHIMADHURA KULIGAI along with external application of KADUGU ENNAI in the management of MAANTHASANNI
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
1.Children have lack of eye contact 2.lack of response 3.Repeatative or restricted behaviour 4.Unawareness of natural urges 5.Acquired speech or lost it 6.Unusual senstivity to sensory stimuli.
Exclusion Criteria
1.Children above 12 years 2.Children below 2 years 3.Seevere and recurrent seizures 4.ADHD 5.CP 6.Infantile hemiplegia 7.Congenital anomalies.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Managing clinical symptoms 45 days
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Government Siddha Medical College and Hospital
🇮🇳Tirunelveli, TAMIL NADU, India
Government Siddha Medical College and Hospital🇮🇳Tirunelveli, TAMIL NADU, IndiaDr B Tamil ElakkiyaPrincipal investigator9578169047balutamilelakkiya@gmail.com